Choroidal Nevus vs. Melanoma: Monitoring Your Eye Freckle
What Is a Choroidal Nevus
A choroidal nevus is a flat or minimally elevated collection of pigmented cells within the choroid, the blood vessel layer beneath the retina. Learning what these spots are, how they form, and where they appear helps put a diagnosis into perspective.
Melanocytes, the cells responsible for producing pigment in the body, are naturally present throughout the choroid. When a cluster of these cells groups together in one area, it creates a visible pigmented spot. The process is similar to the way a freckle or mole develops on the skin, and in most people it happens without any known trigger.
Choroidal nevi can appear anywhere along the back wall of the eye, but they are most commonly found near the macula or the posterior pole. Because the choroid sits directly beneath the retina, the nevus is not visible from the outside. It can only be seen during a dilated eye exam or with specialized retinal imaging.
A benign choroidal nevus is usually gray or slate-green in color, flat or barely raised, and less than two millimeters in thickness. Many nevi have well-defined borders and may show small, bright deposits on the surface called drusen. The presence of surface drusen is generally considered a reassuring sign, because it suggests the lesion has been stable long enough for these deposits to form.
How Common Are Choroidal Nevi
Choroidal nevi are among the most frequently encountered findings during a routine dilated eye exam. Most patients are surprised to learn just how common they are.
Population studies estimate that roughly five to seven percent of adults have at least one choroidal nevus. Because these spots rarely cause symptoms, many people live their entire lives without knowing one is present. The nevus is typically discovered incidentally when an eye care provider examines the retina for other reasons, such as during a diabetic eye screening or a comprehensive annual exam.
Choroidal nevi occur in all ethnicities, though they are identified more frequently in individuals with lighter skin and eye color. Age also plays a role, as the likelihood of detection increases with repeated eye examinations over the years. There is no strong evidence that sun exposure directly causes choroidal nevi, unlike some types of skin moles, although UV protection remains a sound general practice for eye health.
Understanding the Risk of Transformation to Melanoma
The question patients ask most often after being told they have a choroidal nevus is whether it could turn into cancer. While the possibility exists, the overall risk is very low when the lesion displays benign characteristics.
Research estimates that a typical choroidal nevus has roughly a 1 in 8,000 chance of transforming into choroidal melanoma in any given year. Over a lifetime of monitoring, the vast majority of nevi remain completely stable and never require treatment. These statistics are reassuring, but they also underscore why periodic surveillance is the standard of care.
Certain clinical features raise the level of concern and shift a lesion from likely benign to suspicious. Studies by leading ocular oncology researchers have identified measurable characteristics that correlate with a higher probability of growth. A nevus with none of these risk factors carries a transformation risk of approximately three percent over five years, while a lesion with several of them may have a risk exceeding fifty percent over the same period.
Because a small percentage of nevi do grow or develop worrisome features over time, ongoing monitoring gives our retina specialists the best opportunity to catch changes early. Early detection of transformation, when a lesion is still small, significantly improves treatment outcomes and the chances of preserving vision. Monitoring is painless, noninvasive, and provides peace of mind between visits.
Features That Suggest a Suspicious Lesion
Eye care professionals evaluate several specific characteristics when deciding whether a choroidal nevus warrants closer follow-up or referral for treatment. Each of the following features, when present, increases the statistical likelihood that a lesion may behave more like a melanoma than a benign freckle.
Ultrasound measurement of the lesion's height is one of the most important assessments. A nevus that measures more than two millimeters in thickness crosses into a range where the risk of malignancy rises meaningfully. Thicker lesions are tracked more closely and measured at each follow-up visit to detect even subtle growth.
The presence of fluid beneath the retina overlying the nevus is a significant finding. Subretinal fluid can indicate that the lesion is metabolically active, which is more consistent with a growing tumor than a dormant freckle. Fluid accumulation in the eye can also occur in unrelated conditions such as central serous retinopathy, so our retina specialists carefully evaluate the full clinical picture before drawing conclusions.
Lipofuscin, an orange-colored pigment deposit, can sometimes appear on or near a choroidal lesion. Unlike the drusen that are often seen on stable nevi, orange pigment is a byproduct of cellular activity that suggests the lesion may be growing. Fundus autofluorescence imaging is particularly useful for detecting this pigment, even in small amounts that might not be visible during a standard exam.
A choroidal lesion whose margin touches or sits within three millimeters of the optic disc carries a statistically higher risk of growth. The reason for this association is not entirely understood, but it is a consistent finding across multiple large clinical studies. Lesions in this location also pose a greater threat to vision if they do enlarge, because of their closeness to the optic nerve.
Most benign choroidal nevi produce no symptoms at all. When a patient reports blurred vision, flashing lights, or new floaters in the eye where a nevus has been documented, it raises the possibility that the lesion is changing. Any new visual symptom in an eye with a known choroidal nevus should prompt a timely evaluation.
Frequently Asked Questions
Monitoring typically involves a combination of dilated fundus examination and baseline photographic documentation so that future comparisons can be made with precision. At follow-up visits, our retina specialists look for any change in size, shape, color, or associated features. The goal is to establish a stable baseline and then detect even minor deviations from it over time.
Several imaging tools play a role in evaluating a choroidal nevus. Fundus photography captures a detailed color image of the lesion for side-by-side comparison at future visits. Optical coherence tomography (OCT) reveals whether subretinal fluid or retinal changes are present above the lesion. B-scan ultrasound measures the thickness and internal characteristics of the spot, and fundus autofluorescence can highlight orange pigment that may not be obvious on clinical examination.
Choroidal melanoma may present with a noticeable decline in vision, a visible shadow or dark spot in the visual field, or new flashes and floaters. In some cases the tumor is found before symptoms develop, during a routine eye exam. Any documented growth of a previously stable choroidal lesion, even by a fraction of a millimeter, is taken seriously and may prompt referral to an ocular oncologist.
Treatment depends on the size and location of the tumor. Plaque brachytherapy, in which a small radioactive disc is temporarily sutured to the wall of the eye over the tumor, is the most common approach for small to medium melanomas. Larger tumors may require external beam radiation such as proton beam therapy, and in some cases surgical removal of the eye (enucleation) is necessary when the tumor is very large or vision cannot be preserved.
A newly discovered nevus is usually re-examined within three to six months to establish stability. Once baseline imaging confirms that the lesion is not changing, follow-up intervals can often be extended to every six to twelve months. Patients whose nevi have one or more suspicious features are typically monitored more frequently, sometimes every three to four months, until a clear trend is established.
TFSOM stands for 'To Find Small Ocular Melanoma' and is a clinical tool used to remember the key risk factors associated with nevus transformation. The letters correspond to Thickness greater than two millimeters, subretinal Fluid, Symptoms such as blurred vision or flashes, Orange pigment (lipofuscin), and Margin within three millimeters of the optic disc. When multiple TFSOM features are present, the likelihood of the lesion being or becoming a melanoma increases substantially, and our retina specialists may recommend more aggressive monitoring or intervention.
What our Patients say
4.8
Reviews
(3,408)